Literature DB >> 1390323

Cholesterol and coronary disease--outstanding questions.

M F Oliver1.   

Abstract

The role of raised blood cholesterol in causing coronary atheroma is established, and a high dietary intake of saturated fat is a leading cause of coronary disease. Reduction of hypercholesterolemia in middle-aged males reduces CHD incidence, mostly nonfatal myocardial infarction. But there are many unresolved questions that should lead to a selective and moderate approach to the management of hypercholesterolemia. These include lack of the exact knowledge of how raised cholesterol leads to atheroma, equivocal evidence of whether reduction of hypercholesterolemia causes regression of atheroma, uncertainty about how far down cholesterol levels can safely be reduced and whether the cost-benefit always justifies action, the fact that reduction of hypercholesterolemia does not reduce total mortality and may increase noncardiac mortality, and insufficient evidence as to whether the same policies should be adopted for women, the elderly, and adolescents as for middle-aged men.

Entities:  

Mesh:

Year:  1992        PMID: 1390323     DOI: 10.1007/bf00054559

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  30 in total

1.  Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program.

Authors:  K Yano; D M Reed; C J MacLean
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

2.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

3.  A new challenge for America: the National Cholesterol Education Program.

Authors:  C Lenfant
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

4.  Prevention of coronary heart disease--propaganda, promises, problems, and prospects.

Authors:  M F Oliver
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

5.  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

Authors:  M J Martin; S B Hulley; W S Browner; L H Kuller; D Wentworth
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

6.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors:  G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

7.  Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

Authors:  A C Arntzenius; D Kromhout; J D Barth; J H Reiber; A V Bruschke; B Buis; C M van Gent; N Kempen-Voogd; S Strikwerda; E A van der Velde
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

8.  Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

Authors:  L A Carlson; G Rosenhamer
Journal:  Acta Med Scand       Date:  1988

9.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors:  D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

10.  Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.

Authors:  C G Isles; D J Hole; C R Gillis; V M Hawthorne; A F Lever
Journal:  BMJ       Date:  1989-04-08
View more
  1 in total

1.  The impact of cholesterol lowering on patients' mood.

Authors:  M F Coutu; G Dupuis; B D'Antono
Journal:  J Behav Med       Date:  2001-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.